[{"address1": "1000 Skokie Boulevard", "address2": "Suite 350", "city": "Wilmette", "state": "IL", "zip": "60091", "country": "United States", "phone": "847 388 0349", "website": "https://www.monopartx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops MNPR-101-Zr, a clinical stage urokinase plasminogen activator receptor-targeted radiodiagnostic imaging agent; and MNPR-101-RIT, a late preclinical stage radiotherapeutic for advanced cancers. It also develops Camsirubicin, a Phase 1b clinical stage novel analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; and MNPR-202, an analog of Camsirubicin to treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations NorthStar to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was founded in 2014 and is headquartered in Wilmette, Illinois. Monopar Therapeutics Inc. is a subsidiary of Tacticgem LLC.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Christopher M. Starr Ph.D.", "age": 72, "title": "Co-Founder & Independent Executive Chairman of the Board", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 200000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chandler D. Robinson M.B.A., M.D., M.Sc., MBA, MSc", "age": 40, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 710500, "exercisedValue": 0, "unexercisedValue": 56986}, {"maxAge": 1, "name": "Mr. Andrew J. Cittadine M.B.A.", "age": 52, "title": "Chief Operating Officer", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 416700, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Karthik  Radhakrishnan CFA", "age": 53, "title": "CFO, Principal Accounting Officer & Principal Financial Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrice P. Rioux M.D., Ph.D.", "age": 73, "title": "Acting Chief Medical Officer", "yearBorn": 1951, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 30.25, "open": 30.0, "dayLow": 29.5179, "dayHigh": 36.04, "regularMarketPreviousClose": 30.25, "regularMarketOpen": 30.0, "regularMarketDayLow": 29.5179, "regularMarketDayHigh": 36.04, "payoutRatio": 0.0, "beta": 1.315, "forwardPE": -14.87712, "volume": 48159, "regularMarketVolume": 48159, "averageVolume": 72879, "averageVolume10days": 49140, "averageDailyVolume10Day": 49140, "bid": 34.18, "ask": 36.2, "bidSize": 1, "askSize": 1, "marketCap": 214259840, "fiftyTwoWeekLow": 1.72, "fiftyTwoWeekHigh": 54.3, "fiftyDayAverage": 34.1388, "twoHundredDayAverage": 14.071275, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 179283328, "profitMargins": 0.0, "floatShares": 3009980, "sharesOutstanding": 6102530, "sharesShort": 32525, "sharesShortPriorMonth": 35284, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.0053, "heldPercentInsiders": 0.37011, "heldPercentInstitutions": 0.4225, "shortRatio": 0.43, "shortPercentOfFloat": 0.0106, "impliedSharesOutstanding": 6102530, "bookValue": 1.403, "priceToBook": 25.024946, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -6474726, "trailingEps": -1.98, "forwardEps": -2.36, "lastSplitFactor": "1:5", "lastSplitDate": 1723507200, "52WeekChange": 5.111111, "SandP52WeekChange": 0.14239466, "quoteType": "EQUITY", "currentPrice": 35.11, "targetHighPrice": 72.0, "targetLowPrice": 37.0, "targetMeanPrice": 52.25, "targetMedianPrice": 50.0, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 6020084, "totalCashPerShare": 1.141, "totalDebt": 0, "quickRatio": 5.361, "currentRatio": 5.405, "returnOnAssets": -0.59667, "returnOnEquity": -1.12038, "freeCashflow": -3873349, "operatingCashflow": -5951620, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "MNPR", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Monopar Therapeutics Inc.", "longName": "Monopar Therapeutics Inc.", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1740776815, "regularMarketTime": 1740776402, "exchange": "NCM", "messageBoardId": "finmb_304391755", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 16.066118, "regularMarketPrice": 35.11, "earningsTimestampStart": 1742992200, "earningsTimestampEnd": 1743424200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.98, "epsForward": -2.36, "epsCurrentYear": -1.77333, "priceEpsCurrentYear": -19.79891, "fiftyDayAverageChange": 0.97119904, "fiftyDayAverageChangePercent": 0.028448539, "twoHundredDayAverageChange": 21.038727, "twoHundredDayAverageChangePercent": 1.4951543, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1576765800000, "postMarketChangePercent": 3.01908, "postMarketPrice": 36.17, "postMarketChange": 1.06, "regularMarketChange": 4.8600006, "regularMarketDayRange": "29.5179 - 36.04", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 72879, "fiftyTwoWeekLowChange": 33.39, "fiftyTwoWeekLowChangePercent": 19.41279, "fiftyTwoWeekRange": "1.72 - 54.3", "fiftyTwoWeekHighChange": -19.189999, "fiftyTwoWeekHighChangePercent": -0.35340697, "fiftyTwoWeekChangePercent": 511.1111, "displayName": "Monopar Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-01"}]